Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Recursion Pharmaceuticals Inc. (Nasdaq: RXRX)

Recursion is a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation. Enabling its mission is the Recursion Operating System, a platform built across diverse technologies that continuously expands one of the world's largest proprietary biological and chemical datasets, the Recursion Data Universe. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset the Recursion Map, a collection of hundreds of billions of searchable inferences across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. The Company is proudly headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life science industry collective. Recursion also has offices in Toronto, Montreal and the San Francisco Bay Area. *

 

Period Start 2013-01-01 established
  Group Recursion Pharmaceuticals (Group)
Products Industry AI-based drug discovery / AI-based drug development
  Industry 2 artificial intelligence (AI) / machine learning (ML)
Persons Person Gibson, Chris (Recursion Pharmaceuticals 201907 CEO + Co-Founder)
  Person 2 Virani, Shafique (Recursion 202009 Chief Corp Development Officer formerly Roche Global Head Neuroscience Partnering)
     
Region Region Salt Lake City, UT
  Country United States (USA)
  Street 41 South Rio Grande Street
  City 84101 Salt Lake City, UT
  Tel +1-385-269-0203
    Address record changed: 2024-01-05
     
Basic data Employees D: 101 to 500 (2021-02-17)
  Currency USD
  Annual sales 3,962,000 (revenue, total, consolidated (2020) 2020-12-31)
  Profit -87,006,000 (2020-12-31)
  Cash 262,126,000 (2020-12-31)
     
    * Document for »About Section«: Recursion Pharmaceuticals, Inc.. (12/7/21). "Press Release: Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Recursion Pharmaceuticals (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top